Adverse Drug Reaction Markup Language
Names
More detailed information about this field from each metasource.
Adverse Drug Reaction Markup Language
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
EU-ADR ML
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Names
More detailed information about this field from each metasource.
Adverse Drug Reaction Markup Language
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
EU-ADR ML
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Names
More detailed information about this field from each metasource.
Adverse Drug Reaction Markup Language
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
EU-ADR ML
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
This source may no longer be available. No known URL could be resolved successfully.
The Adverse Drug Reaction Markup Language (EU-ADR ML) was created to as part of the EU-ADR project. The ultimate aim of this project was to develop an innovative approach to the early detection of adverse drug reactions. The status of this format is uncertain as FAIRsharing cannot find documentation for the format itself beyond what is available in this record.
Description
More detailed information about this field from each metasource.
The Adverse Drug Reaction Markup Language (EU-ADR ML) was created to as part of the EU-ADR project. The ultimate aim of this project was to develop an innovative approach to the early detection of adverse drug reactions. The status of this format is uncertain as FAIRsharing cannot find documentation for the format itself beyond what is available in this record.
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Webpage:
https://www.euadr-project.orgWebpage
More detailed information about this field from each metasource.
https://www.euadr-project.org
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
The EU-ADR project: preliminary results and perspective
PMID: 19745234
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Publications
More detailed information about this field from each metasource.
The EU-ADR project: preliminary results and perspective
PMID: 19745234
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
-
The EU-ADR project: preliminary results and perspective
PubMed citations: 22.
22 articles citing: The EU-ADR project: preliminary results and perspective
Signal Detection of Potentially Drug-Induced Liver Injury in Children Using Electronic Health Records. PMID:32373564
Electronic health records and polygenic risk scores for predicting disease risk. PMID:32235907
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? PMID:30269245
Adverse Reactions Associated With Cannabis Consumption as Evident From Search Engine Queries. PMID:29074469
From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. PMID:28840504
Evaluation Considerations for Secondary Uses of Clinical Data: Principles for an Evidence-based Approach to Policy and Implementation of Secondary Analysis. PMID:28480477
Accuracy of an automated knowledge base for identifying drug adverse reactions. PMID:27993747
Electronic health records to facilitate clinical research. PMID:27557678
Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs. PMID:27061849
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations. PMID:27028286
The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study. PMID:25683723
Longitudinal medical records as a complement to routine drug safety signal analysis. PMID:25623045
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. PMID:24446276
Gathering and exploring scientific knowledge in pharmacovigilance. PMID:24349421
Ongoing challenges in pharmacovigilance. PMID:24264884
A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records. PMID:23907285
Postmarket drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queries. PMID:23778053
The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist. PMID:23640186
A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. PMID:23315292
Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project. PMID:23195749
Physicians' perceptions on the usefulness of contextual information for prioritizing and presenting alerts in Computerized Physician Order Entry systems. PMID:23031275
Automatic filtering and substantiation of drug safety signals. PMID:22496632
Tags:
Tags
More detailed information about this field from each metasource.
adverse reaction
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
disease
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
drug
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
electronic health record
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
target
metasource: Fairsharing.org
version: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Tags
More detailed information about this field from each metasource.
adverse reaction
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
disease
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
drug
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
electronic health record
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
target
metasource: Fairsharing.orgversion: FAIRsharing.org: EU-ADR ML; Adverse Drug Reaction Markup Language; DOI: https://doi.org/10.25504/FAIRsharing.qw67v6; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
adverse reaction disease drug electronic health record target
Need help integrating and/or managing biomedical data?